Select your language
Update on COVID-19 vaccination in Syria, 16 February 2021
Photo credit: WHO/Syria
16 February 2021 – COVAX is the vaccines pillar of the ACT-Accelerator [1], convened by the Coalition for Epidemic Preparedness and Innovations (CEPI), GAVI - the Vaccine Alliance (GAVI) and WHO.
Syria is one of the 92 countries eligible for Advanced Market Distribution (AMD) of COVID-19 vaccines under the COVAX facility, a partnership between the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and the Global Alliance for Vaccines and Immunization (GAVI).
In coordination with GAVI, WHO and UNICEF continue providing detailed technical assistance to and sharing guidelines with the national health authority and established committees, such as the high level National Coordination Committee, CTAG-national COVID-19 Technical Advisory Group and Inter-agency Coordination Committee.
Update on COVID-19 vaccination in Syria, 9 February 2021
Photo credit: WHO/Syria
9 February 2021 – COVAX is the vaccines pillar of the ACT-Accelerator[1], convened by the Coalition for Epidemic Preparedness Innovations (CEPI), the Global Alliance for Vaccines and Immunization (GAVI) and WHO.
Syria is one of the 92 countries eligible for Advanced Market Distribution (AMD) of COVID-19 vaccines under the COVAX facility, a partnership between the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and the Global Alliance for Vaccines and Immunization (GAVI).
In coordination with GAVI, WHO and UNICEF continue providing detailed technical assistance to and sharing guidelines with the national health authority and established committees, such as NCC- high level National Coordination Committee, CTAG-national COVID-19 Technical Advisory Group and ICC- Inter-agency Coordination Committee.
Update on COVID-19 vaccination in Syria, 26 January 2020
Photo credit: WHO/Syria
26 January 2021 – The Vaccine Request Form - Part A of the COVID-19 vaccine application document was signed by the Minister of Health and sent to GAVI - the Vaccine Alliance on 15 December 2020. Part B (the legal part) is still awaiting Ministry of Health approval (with WHO follow up).
1. Coordination framework established
All the necessary coordination committees (National Coordination Committee, cTAG COVID-19 Technical Advisory Group and ICC Inter-Agency Coordination Committee) along with their adjusted terms of reference have been approved by the Government of Syria.
2. National readiness assessment
VIRAT/VRAF version updated tool includes planning and coordination, budgeting, regulatory, prioritization, targeting and surveillance, service delivery, training and supervision, monitoring and evaluation, vaccine cold-chain, logistics, safety surveillance, and demand generation and communication – a set of 50 key operational activities:
